Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
18 Results for "
MOBS
" in MedChemExpress (MCE) Product Catalog:
Products (18)
18 Results for "MOBS" in MCE Product Catalog:
Cat. No.: HY-W127629
CAS No.: 115724-21-5
1
Target:
Research Areas:
4-Bromo-2-methoxyphenol (4-Bromoguaiacol) is a phenolic compound. 4-Bromo-2-methoxyphenol serves as a synthetic intermediate for the preparation of PT70. 4-Bromo-2-methoxyphenol acts as a precursor for generating masked ortho-benzoquinone (MOB) 6 .
Cat. No.: HY-P3120
CAS No.: 1926163-82-7
Target:
Research Areas:
Cat. No.: HY-RS08577
Target:
Research Areas:
MOB4 Human Pre-designed siRNA Set A contains three designed siRNAs for MOB4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS08573
Target:
Research Areas:
MOB1A Human Pre-designed siRNA Set A contains three designed siRNAs for MOB1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS08575
Target:
Research Areas:
MOB2 Human Pre-designed siRNA Set A contains three designed siRNAs for MOB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS20297
Target:
Research Areas:
Mob4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mob4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS26805
Target:
Research Areas:
Mob4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Mob4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS08574
Target:
Research Areas:
MOB1B Human Pre-designed siRNA Set A contains three designed siRNAs for MOB1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS08576
Target:
Research Areas:
MOB3B Human Pre-designed siRNA Set A contains three designed siRNAs for MOB3B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-W141815
CAS No.: 120944-75-4
Target:
Research Areas:
Cat. No.: HY-W141814
CAS No.: 106306-57-4
Target:
Research Areas:
Cat. No.: HY-180517
CAS No.: 2629270-03-5
Target:
Research Areas:
PP48 is a compound that interacts with MOB4, with a pTE50 value of 5.4. PP48 interacts with MOB4 (Cys134) .
Cat. No.: HY-RS21652
Target:
Research Areas:
Mob1a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mob1a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS28170
Target:
Research Areas:
Mob1a Rat Pre-designed siRNA Set A contains three designed siRNAs for Mob1a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS19459
Target:
Research Areas:
Mob1b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mob1b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-RS25952
Target:
Research Areas:
Mob1b Rat Pre-designed siRNA Set A contains three designed siRNAs for Mob1b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
Cat. No.: HY-P3120A
CAS No.: 2237216-67-8
Target:
Research Areas:
- 1
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
